ClinicalTrials.gov
public full text
Public Domain
Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705)
The purpose of this study is to evaluate the effectiveness of Org 25935 vs. placebo given in combination with cognitive-behavioral therapy (CBT) to reduce the symptoms of panic disorder. It is hypothesized that treatment with Org 25935 at a dose of 4 mg or 12 mg will differ significantly from placebo with respect to the Panic Disorder Severity Scale (PDSS) total score over 3 weeks of therapy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Cognitive Behavioral Therapy in Panic Disorder#900046
- D-cycloserine Augmented CBT for Panic Disorder#846749
- Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia#918775
- Staccato Alprazolam in Panic Attack#916376
- Advancing CBT for panic disorder and agoraphobia by integrating a digital intervention into treatment: a pilot randomized controlled trial / Ece Atik, Jan Kalde, Johannes Stricker, Magnus Schückes, Peter Neudeck, Reinhard Pietrowsky, Andre Pittig#619704
Record · ID 874451
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive